Screener
IBRN vs BMED
iShares Neuroscience and Healthcare ETF vs iShares Health Innovation Active ETF
Key differences
- IBRN costs 0.08% less per year.
- IBRN follows a index tracking strategy; BMED uses active selection.
- Over the last 3 years, IBRN has delivered higher annualized returns.
Side-by-side comparison
| IBRN | BMED | |
|---|---|---|
| Annual cost (TER) | 0.47% | 0.55% |
| Fund size (AUM) | $5M | $10M |
| Since | 2022 | 2020 |
| Dividend yield | 0.93% | 0.00% |
| Asset class | equity | equity |
| Region | — | north america |
| Strategy | index tracking | active selection |
| CAGR 1Y | +56.8% | +18.0% |
| CAGR 3Y | +10.6% | +4.9% |
| CAGR 5Y | N/A | +0.1% |
| Sharpe 3Y | 0.39 | 0.16 |
| Volatility 1Y | 25.00% | 14.94% |
| Max drawdown | -35.39% | -36.44% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to IBRN and BMED
Explore further